These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2552981)

  • 1. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
    Clas F; Euteneuer B; Stemmer F; Loos M
    Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-independent killing of gram-negative bacteria via the classical pathway of complement.
    Loos M; Clas F
    Immunol Lett; 1987 Feb; 14(3):203-8. PubMed ID: 3032781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage C1q: characterization of a membrane form of C1q and of multimers of C1q subunits.
    Martin H; Heinz HP; Reske K; Loos M
    J Immunol; 1987 Jun; 138(11):3863-7. PubMed ID: 3495575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ; Isliker H
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fc-recognizing, collagen-like C1q molecule is a putative type II membrane protein of macrophages.
    Kaul M; Loos M
    Behring Inst Mitt; 1993 Dec; (93):171-9. PubMed ID: 8172565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria.
    Clas F; Loos M
    Infect Immun; 1982 Sep; 37(3):935-9. PubMed ID: 6752030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
    J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.
    Schweinle JE; Hitchcock PJ; Tenner AJ; Hammer CH; Frank MM; Joiner KA
    J Clin Invest; 1989 Feb; 83(2):397-403. PubMed ID: 2492308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.